Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular
Mortality - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

echocardiogram) may be expected to facilitate the identification of patients with chest pain of
an ischemic etiology (angina). In a patient presenting to the emergency department with …

Background Uncertainties persist about the magnitude of associations of diabetes mellitus
and fasting glucose concentration with risk of coronary heart disease and major stroke …

Context Associations of major lipids and apolipoproteins with the risk of vascular disease
have not been reliably quantified. Objective To assess major lipids and apolipoproteins in …

Objectives To determine the combination of drugs and vitamins, and their doses, for use in a
single daily pill to achieve a large effect in preventing cardiovascular disease with minimal …

Human epidemiologic and genetic evidence using the Mendelian randomization approach
in large-scale studies now strongly supports that elevated lipoprotein (a)[Lp (a)] is a causal …

Background—The present study tested the hypothesis that simple variables, such as waist
circumference and fasting plasma triglyceride (TG) concentrations, could be used as …

Background—Studies of the association between the plasma concentration of lipoprotein
(a)[Lp (a)] and coronary heart disease (CHD) have reported apparently conflicting findings …

Coronary artery disease is the No. 1 cause of death in the developed world. Effective means
of treatment such as drug therapy to lower cholesterol levels are available, but clinical …

Background In view of consistently high cardiovascular morbidity and mortality rates,
international efforts are aimed at developing tools for more precise risk prediction to allow …